Lung clearance index (LCI) as a sensitive marker of post-transplant bronchiolitis obliterans syndrome (BOS)

M. Driskel (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom), M. Al-Aloul (Manchester, United Kingdom)

Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Session: The value of lung function testing in various pathophysiological conditions
Session type: Thematic Poster
Number: 2430
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Driskel (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom), M. Al-Aloul (Manchester, United Kingdom). Lung clearance index (LCI) as a sensitive marker of post-transplant bronchiolitis obliterans syndrome (BOS). 2430

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung clearance index in detection of post-transplant bronchiolitis obliterans syndrome
Source: ERJ Open Res, 5 (4) 00164-2019; 10.1183/23120541.00164-2019
Year: 2019



Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020




The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007


FVC/slow VC (FVC/SVC) as a marker for small airways obstruction, evaluated in bronchiolitis obliterans syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 686s
Year: 2005

Pulmonary function and clinical outcome of patients with post-infectious bronchiolitis obliterans (BO)
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Acinar ventilation heterogeneity (Sacin) assessed by nitrogen multiple breath washout is an accurate and sensitive marker of bronchiolitis obliterans (BO)
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Evaluation of the differences of small airways impairment between chronic obstructive disease (COPD) and bronchiolitis obliterans syndrome (BOS) by using impulse oscillometory
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

Lung clearance index in patients with bronchiolitis obliterans
Source: International Congress 2016 – Paediatric respiratory infection
Year: 2016

Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients?
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Source: Eur Respir Rev 2008; 17: 90-92
Year: 2008



Proteomic analysis of broncho alveolar lavage fluid (BAL-f) in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS)
Source: Eur Respir J 2006; 28: Suppl. 50, 120s
Year: 2006

Pulmonary circulation changes in children with bronchiolitis obliterans (BO)
Source: Eur Respir J 2005; 26: Suppl. 49, 29s
Year: 2005

Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19
Year: 2004

Do nitrites (NO2) and nitrates (NO3) have a role in the development of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008



Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 177s
Year: 2004

Early diagnosis of bronchiolitis obliterans syndrome diagnosis after lung transplantation using functional respiratory imaging (FRI)
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016